allodynia glp 1 treatment Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System GLP 1 + GIP /

Alanine scanning studies have identified specific amino acids, including His7, Gly10, Phe12, Thr13, Asp15, Phe28, and Ile29, that play crucial roles in receptor binding and activation

F.SmithW.HighleyJ

At some point, a weight loss plateau is expected

Interestingly, supplementation of metformin with 1.5 mg dulaglutide per week in the treatment of T2MD in obese patients with severe impairment of glycosylated hemoglobin A1c (HbA1c) was reported to bring lasting benefits in the control of glucose metabolism and body weight (173)

1 Separating Myth from Fact Myth : Anyone can take GLP-1 weight-loss drugs

5-7 Genetic predisposition, epigenetics, lifestyle, as well as an imbalance of energy intake/expenditure could lead to a dysmetabolic milieu, which is the cornerstone for the development of both, NAFLD/NASH and CVD